Abstract:The PGC2 schizophrenia (SCZ) GWAS shows that variation in non-coding regions is responsible for most of the common variation heritability of the disease, suggesting risk variants alter gene expression. Therefore, comparing differences in gene expression between cases and controls may provide a direct approach for studying the etiology of SCZ. We studied transcriptome expression profiles of Cultured Neural progenitor cells derived from Olfactory Neuroepithelium lines (CNON) from 144 SCZ and 111 control individuals using RNA-Seq and identified 53 differentially expressed (DEX) genes (FDR<0.10). Most DEX genes are implicated in Wnt or Notch signaling, or the metabolism of serine/glutamine/asparagine. DEX genes show enrichment for overlap with significant variants from the SCZ GWAS, and for GO terms related to neurodevelopment: cell differentiation, migration, neurogenesis, and synapse assembly. Our findings show the utility of gene expression analysis of neural progenitors for deciphering molecular aberrations associated with, and potentially causing, schizophrenia. Introduction. Schizophrenia (SCZ) is a devastating psychiatric disorder with estimated lifetime prevalence of 0.55% worldwide (1). With heritability of about 81% (2), genetics plays a critical role in the disease’s etiology. Although causes of the disease remain a mystery, many direct and indirect pieces of evidences indicate that aberrations in brain development are major contributors (3–5). Post-mortem studies of the brains of individuals with SCZ provide important information about functional changes associated with the disease, but it is unlikely that the gene expression profiles of fully differentiated cells can identify all the genes responsible for aberrations in neurodevelopment. Even though the genetic mechanisms regulating neurodevelopment are poorly known, it seems reasonable to suggest that regulation of cell migration and the balance between cell division and differentiation of neuronal cells are critical . CC-BY-NC-ND 4.0 International license a certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under The copyright holder for this preprint (which was not this version posted October 26, 2017. ; https://doi.org/10.1101/209197 doi: bioRxiv preprint

Analysis of the caudate nucleus transcriptome in individuals with schizophrenia highlights effects of antipsychotics and new risk genes

Dopamine signaling enriched striatal gene set predicts striatal dopamine synthesis and physiological activity in vivo

Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis

Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia

Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function

Transcriptomic analysis of postmortem brain identifies dysregulated splicing events in novel candidate genes for schizophrenia.

Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases

Biological Insights from Schizophrenia-associated Loci in Ancestral Populations

Consensus molecular environment of schizophrenia risk genes in coexpression networks shifting across age and brain regions

Profiling gene expression in the human dentate gyrus granule cell layer reveals insights into schizophrenia and its genetic risk

Gene expression imputation across multiple brain regions provides insights into schizophrenia risk

An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data

Brain transcriptome-wide association study implicates novel risk genes underlying schizophrenia risk

Polygenic risk for schizophrenia converges on alternative polyadenylation as molecular mechanism underlying synaptic impairment

Gene expression in patient-derived neural progenitors provide insights into neurodevelopmental aspects of schizophrenia

Comprehensive Pathway Analyses of Schizophrenia Risk Loci Point to Dysfunctional Postsynaptic Signaling

Joint-Tissue Integrative Analysis Identified Hundreds of Schizophrenia Risk Genes

Analysis of single-cell transcriptome data from a mouse model implicates protein synthesis dysfunction in schizophrenia

Synergistic effects of common schizophrenia risk variants

Connectome Disconnectivity and Cortical Gene Expression in Patients with Schizophrenia

Multi-scale Analysis of Schizophrenia Risk Genes, Brain Structure, and Clinical Symptoms Reveals Integrative Clues for Subtyping Schizophrenia Patients